主要工作经历：

 1999.12-2003.10 ：中国台湾及美国微晶生物科技股份有限公司(U-Vision Biotech) ，首席技术长，总裁  ；

 2000.01-2004.12 ：中国台湾中央研究院生农所(Academic Sinica, Bio-Agricultural Science) ，副研究员；

 2003.11-2004.04 ：中国台湾竹北生物医学园区(National Biomedical Science Park) ，副主任；

 2004.01-2004.07 ：中国台湾台大医学院医研部(National Taiwan University , Dept. of Medical Research) ，副教授；

 2004.07-2006.12 ：中国台湾及美国赛亚集团基康生物科技公司(Genecore&Vita Genomics Biotechnologies.Inc.) ，总经理（General manager）；

 2007.01-2008.09 ：中国上海生物芯片有限公司(Shanghai Bio Corporation ,SBC)  及美国MaxyBio Corporation (SBC at USA) ，国际商务执行主任和副总（Executive Director of International Project Management; Vice President）；

 2009.09-2010.07 ：美国贝克曼库尔特有限公司(Beckman Coulter Inc.) ，大中华市场与商务开发总监(Director MKT&BD) ；

 2010.4-至今：广东药学院，客座教授；

 2010.8-至今：佰香汇生物科技（厦门）有限公司，执行董事、技术总监；

 2010.10 至今：中国厦门大学药学院转化医学中心，执行主任，教授；

 2012.1-至今：福建肿瘤医院，特聘客座研究员；

 2012.12-至今：芮宝（厦门）生物医学有限公司,  创办人,  执行董事；

 2013.1-至今：厦门火炬高技术产业开发区，招商与技术顾问；

 2014年：厦门市医疗器械体外诊断试剂类审评专家

论文论著：

1. YQ Wang, JJ Song, X Han, YY Liu, XH Wang，ZM Li，Tzeng CM *. Effects of angiopoietin-1 on inflammatory injury in endothelial progenitor cells and blood vessels, Current Gene Therapy, 2013. (SCI impact factor: 5.318；JCR二区)

2. Cai, Liang Liang, HuiMing Ye, Xiao Nan Lv, Yun Long Wu, HuanJing Zhang,Li Mou Zheng and Tzeng CM *. 25-(OH)VitD3, As a Risk Indicator in Diagnosis of Adenocarcinoma. Curr Drug Targets.2013,14(11):1367-76.(SCI impact factor: 3.553 )

3. Xiao Nan Lv, Zhu Jun Liu, Huan Jing Zhang, Tzeng CM *.Aromatherapy on Central Nerve System (CNS): Therapeutic mechanism and its associated genes. Current Drug Targets.2013,14(8):872-879 (SCI impact factor: 3.553,JCR二区 )

4. Qilin Ma, Xingkai An, Zhiming Li, Huanjing Zhang, Wenqing Huang, Liangliang Cai, Peng Hu, Qing Lin*, Tzeng CM *. P268S in NOD2 associates With susceptibility to Parkinson's disease in Chinese Population. Behavioral and Brain Functions. 2013,9:19 ((SCI impact factor:2.13)

5. Hui-Ming Ye,Yi-Zhuo Lu,Xian-Ming Liang,Yong-Zhi Lin ,Yi Li, Zhong-Ying Zhang, Tzeng CM *.Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients. Clinical Laboratory.2013 (SCI impact factor: 0.9)

6. Guoyan Liu,Kunhong Liu,Yin Li, Chao Pan, Jiqin Su,Hongfeng Liao,Renxiang Yv, Zhaohui Li, Li Yuan, Huanjing Zhang, Tzeng CM *. Novel cancerization marker,TP53, and its role in distinguishing normal tissue adjacent to cancerous tissue from normal tissue adjacent to benign tissue. World Journal of Surgical Oncology. 2012,10:252. (SCI impact factor: 1.12)

7. HL Zhang, L Ruan,LM Zheng, Daivid Whyte, Tzeng CM,XW Zhou. Association between class III β-tubulin expression and response to paclitaxel/vinorbine-based chemotherapy for non-small cell lung cancer: A meta-analysis.Lung cancer. 2012,77(1):9-15. (SCI impact factor: 3.6)

8. 曾骥孟.临床病毒学. 科学出版社，2012.

9. SK Chiu, JT Ma, MH, Hsieh, DL, Lu and Tzeng CM *. Unique Marker Finder Algorithm Generates Molecular Diagnostic Markers. Int.J. Bioinformatics. 2011,7(1): 24-42.

10. Tzeng CM. Clinical Virology. Border NY 2010.

11. C.C. Chen,WC Ku,SK Chiu, Tzeng CM *.Deoxyribonucleic acid hybridization acceleration by photovoltaic effect. Appl.Phys.Lett.2006，89(23): 233902-1-2. (SCI impact factor: 4.184)

12. Tsai, NP, Wu, YC, Chen, JW, Wu, CF, Tzeng CM *, Syu, WJ*. Multiple functions of l0036 in the regulation of the pathogenicity island of enterohaemorrhagic Escherichia coli O157 : H7. Biochemical Journal. 2006,393(Pt 2):591-9. (SCI impact factor:6.10 )

13. E Lin,Y Hwang and Tzeng CM *.A Comparison of Taiwanese and Han Chinese Populations Based on Pharmacogenomics of Antidepressants with HapMap Database. J Hum Genet. 2006, 367:1177-1182. (SCI impact factor:3.68 )

14. E Lin,Y Hwang and Tzeng CM *.A Case Study of the Utility of the HapMapDatabase for Pharmacogenomic Haplotype Analysis in the Taiwanese Population. Molecular Diagnosis &Therapy. 2006, 10(6): 367-370. (SCI impact factor:3.45 )

15. B Jiang,ZZ Zhu,F Liu,LF Hou, J Gu, E Chen, Tzeng CM,G Zhu. Prevalence of Mutation in the Epidermal Growth Factor Receptor Gene in Chinese Patients with Non-small Cell Lung Cancer. Clinical Oncology.2006,18:635-639.Lettter.

16. Shyur LF, Chen CH, Lo CP,Wang SY ,Kang PL, Sun SJ,Chang CA, Tzeng CM and Yang NS*. Induction  of Apoptosis  in MCF-7 Human Breast Cancer Cells by Phytochemicals from Anoectochilus  formosanus. J. BioMedical Science.2004, 11(6): 928-939. (SCI impact factor:3.12)

17. Yang NS, Shyur LF, Chen CH, Wang SY and Tzeng CM*. Medicinal Herb Extract and a Single-Compound Drug Confer Similar Complex Pharmacogenomic Activities in MCF-7 Cells. J. BioMedical Science.2004, 11: 418-422. (SCI impact factor:3.12)